Shanghai, China
Novartis is planning to build an integrated research and development center in Shanghai, China. As the eighth site in the company's R&D network, the center will focus on infectious causes of cancer endemic to China and Asia and pharmaceutical research. Scientists will initially occupy a 5,000-square meter facility slated to open in May of 2007. Construction will begin in July 2007 on a permanent 38,000-square meter building to house 400 scientists. The site will also include an integrated exploratory development center for collaboration with academic centers to foster the growth of emerging biomedical technologies. The investment for both project phases is estimated at $100 million.
